News

Gary Lowenthal Joins Focused Ultrasound Foundation’s Council

The Focused Ultrasound Foundation is pleased to welcome Gary Lowenthal to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.

Mr. Lowenthal is a retired educator, entrepreneur, and executive with a career spanning education, international service, and business leadership.

He began his professional journey as a teacher serving in the Peace Corps, teaching in underserved communities in Fiji. Upon returning to the US, he held an executive position at Bloomingdale’s before founding The Boyds Collection Ltd. in 1979, a company that became a leader in the plush and figurine market renowned for its lovingly crafted handmade collectibles. As “the Head Bean Hisself,” he personally designed much of the original Boyds Bears lineup, infusing each piece with his sense of humor, warmth, and a clear eye for character.

In addition to his business ventures, Mr. Lowenthal remained dedicated to education and taught entrepreneurship to budding innovators at Mount St. Mary’s University.

“Gary’s unique blend of creativity, entrepreneurial spirit, and dedication to service makes him a tremendous asset to the Foundation’s Council,” said Foundation Chairman Neal F. Kassell, MD. “His insight and energy will strengthen our efforts to advance this transformative technology and expand its access to patients.”

“It’s an honor to join the Foundation’s Council and support such groundbreaking work,” Mr. Lowenthal said. “I’m inspired by the potential of focused ultrasound to revolutionize medicine, and I look forward to contributing to a mission that has real, lasting impact on people’s lives.”

Born and raised in New York City, Mr. Lowenthal earned a bachelor of science degree in biology and a master’s degree in biology and education from Alfred University.

Read more here.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation